Kiura, K <br/><br/>
An adriamycin-resistant subline is more sensitive than the parent human small cell lung cancer cell line to lonidamine.  [electronic resource] 

 -  Anti-cancer drug design  Dec 1992 
 - 463-70 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0266-9536 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Carcinoma, Small Cell--drug therapy<br/>Cisplatin--pharmacology<br/>Doxorubicin--pharmacology<br/>Drug Resistance<br/>Drug Screening Assays, Antitumor<br/>Etoposide--pharmacology<br/>Humans<br/>Indazoles--pharmacology<br/>Lung Neoplasms--drug therapy<br/>Tumor Cells, Cultured